P2RY2 and atherosclerosis: Table 1 summarizes the ED caused by purinergic receptors activation or inhibition, and Fig. 1 summarizes the role of purinergic receptors in atherosclerosis via their regulation of vascular tone, inflammation, and platelet aggregation.